Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

280 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparative Effectiveness of a Second Tumor Necrosis Factor Inhibitor Versus a Non-Tumor Necrosis Factor Biologic in the Treatment of Patients With Polyarticular-Course Juvenile Idiopathic Arthritis.
Mannion ML, Amin S, Balevic S, Chang ML, Correll CK, Kearsley-Fleet L, Hyrich KL, Beukelman T; Childhood Arthritis and Rheumatology Research Alliance Registry Investigators and the UK Juvenile Idiopathic Arthritis Biologics Register Investigators. Mannion ML, et al. Among authors: hyrich kl. Arthritis Care Res (Hoboken). 2024 Mar 31. doi: 10.1002/acr.25339. Online ahead of print. Arthritis Care Res (Hoboken). 2024. PMID: 38556945
Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: results from the British Society for Rheumatology Biologics Register.
Dixon WG, Watson KD, Lunt M, Mercer LK, Hyrich KL, Symmons DP; British Society For Rheumatology Biologics Register Control Centre Consortium; British Society for Rheumatology Biologics Register. Dixon WG, et al. Among authors: hyrich kl. Arthritis Care Res (Hoboken). 2010 Jun;62(6):755-63. doi: 10.1002/acr.20129. Arthritis Care Res (Hoboken). 2010. PMID: 20535785 Free PMC article.
Rituximab or a second anti-tumor necrosis factor therapy for rheumatoid arthritis patients who have failed their first anti-tumor necrosis factor therapy? Comparative analysis from the British Society for Rheumatology Biologics Register.
Soliman MM, Hyrich KL, Lunt M, Watson KD, Symmons DP, Ashcroft DM; British Society for Rheumatology Biologics Register. Soliman MM, et al. Among authors: hyrich kl. Arthritis Care Res (Hoboken). 2012 Aug;64(8):1108-15. doi: 10.1002/acr.21663. Arthritis Care Res (Hoboken). 2012. PMID: 22422731 Free PMC article.
The association between low socioeconomic status with high physical limitations and low illness self-perception in patients with juvenile idiopathic arthritis: results from the Childhood Arthritis Prospective Study.
Verstappen SM, Cobb J, Foster HE, Fu B, Baildam E, Wedderburn LR, Davidson JE, Ioannou J, Chieng A, Hyrich KL, Thomson W. Verstappen SM, et al. Among authors: hyrich kl. Arthritis Care Res (Hoboken). 2015 Mar;67(3):382-9. doi: 10.1002/acr.22466. Arthritis Care Res (Hoboken). 2015. PMID: 25187470 Free PMC article.
Growth in children and adolescents with juvenile idiopathic arthritis over 2 years of treatment with etanercept: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study.
Kearsley-Fleet L, Hyrich KL, Davies R, Lunt M, Southwood TR; British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study. Kearsley-Fleet L, et al. Among authors: hyrich kl. Rheumatology (Oxford). 2015 Jul;54(7):1279-85. doi: 10.1093/rheumatology/keu489. Epub 2015 Jan 30. Rheumatology (Oxford). 2015. PMID: 25638806
Medically Significant Infections Are Increased in Patients With Juvenile Idiopathic Arthritis Treated With Etanercept: Results From the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study.
Davies R, Southwood TR, Kearsley-Fleet L, Lunt M, Hyrich KL; British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study. Davies R, et al. Among authors: hyrich kl. Arthritis Rheumatol. 2015 Sep;67(9):2487-94. doi: 10.1002/art.39197. Arthritis Rheumatol. 2015. PMID: 25989609 Free PMC article.
Investigating CD11c expression as a potential genomic biomarker of response to TNF inhibitor biologics in whole blood rheumatoid arthritis samples.
Smith SL, Eyre S, Yarwood A, Hyrich K, Morgan AW, Wilson AG, Isaacs J; Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate 6; Plant D, Barton A. Smith SL, et al. Arthritis Res Ther. 2015 Dec 14;17:359. doi: 10.1186/s13075-015-0868-y. Arthritis Res Ther. 2015. PMID: 26667261 Free PMC article.
Factors associated with improvement in disease activity following initiation of etanercept in children and young people with Juvenile Idiopathic Arthritis: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study.
Kearsley-Fleet L, Davies R, Lunt M, Southwood TR, Hyrich KL. Kearsley-Fleet L, et al. Among authors: hyrich kl. Rheumatology (Oxford). 2016 May;55(5):840-7. doi: 10.1093/rheumatology/kev434. Epub 2015 Dec 31. Rheumatology (Oxford). 2016. PMID: 26721878 Free PMC article.
280 results